International Journal of Epidemiology. Publish Ahead of Print():, OCTOBER 9, 2017
Issn Print: 0300-5771
Publication Date: October 9, 2017
Body mass index and breast cancer survival: a Mendelian randomization analysis
Qi Guo;Stephen Burgess;Constance Turman;Manjeet Bolla;Qin Wang;Michael Lush;Jean Abraham;Kristiina Aittomäki;Irene Andrulis;Carmel Apicella;Volker Arndt;Myrto Barrdahl;Javier Benitez;Christine Berg;Carl Blomqvist;Stig Bojesen;Bernardo Bonanni;Judith Brand;Hermann Brenner;Annegien Broeks;Barbara Burwinkel;Carlos Caldas;Daniele Campa;Federico Canzian;Jenny Chang-Claude;Stephen Chanock;Suet-Feung Chin;Fergus Couch;Angela Cox;Simon Cross;Cezary Cybulski;Kamila Czene;Hatef Darabi;Peter Devilee;W Diver;Alison Dunning;Helena Earl;Diana Eccles;Arif Ekici;Mikael Eriksson;D Evans;Peter Fasching;Jonine Figueroa;Dieter Flesch-Janys;Henrik Flyger;Susan Gapstur;Mia Gaudet;Graham Giles;Gord Glendon;Mervi Grip;Jacek Gronwald;Lothar Haeberle;Christopher Haiman;Per Hall;Ute Hamann;Susan Hankinson;Jaana Hartikainen;Alexander Hein;Louise Hiller;Frans Hogervorst;Bernd Holleczek;Maartje Hooning;Robert Hoover;Keith Humphreys;David Hunter;Anika Hüsing;Anna Jakubowska;Arja Jukkola-Vuorinen;Rudolf Kaaks;Maria Kabisch;Vesa Kataja;Julia Knight;Linetta Koppert;Veli-Matti Kosma;Vessela Kristensen;Diether Lambrechts;Loic Le Marchand;Jingmei Li;Annika Lindblom;Sara Lindström;Jolanta Lissowska;Jan Lubinski;Mitchell Machiela;Arto Mannermaa;Siranoush Manoukian;Sara Margolin;Federik Marme;John W Martens;Catriona McLean;Primitiva Menéndez;Roger Milne;Anna Marie Mulligan;Taru Muranen;Heli Nevanlinna;Patrick Neven;Sune Nielsen;Børge Nordestgaard;Janet Olson;Jose I Perez;Paolo Peterlongo;Kelly-Anne Phillips;Christopher Poole;Katri Pylkäs;Paolo Radice;Nazneen Rahman;Thomas Rüdiger;Anja Rudolph;Elinor Sawyer;Fredrick Schumacher;Petra Seibold;Caroline Seynaeve;Mitul Shah;Ann Smeets;Melissa Southey;Rob A E Tollenaar;Ian Tomlinson;Helen Tsimiklis;Hans-Ulrich Ulmer;Celine Vachon;Ans M van den Ouweland;Laura Van’t Veer;Hans Wildiers;Walter Willett;Robert Winqvist;M Zamora;Georgia Chenevix-Trench;Thilo Dörk;Douglas Easton;Montserrat García-Closas;Peter Kraft;John Hopper;Wei Zheng;Marjanka Schmidt;Paul D Pharoah;
1Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK2MRC Biostatistics Unit, University of Cambridge, Cambridge, UK3Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA4Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK5Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK6Cambridge Experimental Cancer Medicine Centre, Cambridge, UK7Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland8Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada9Department of Molecular Genetics, University of Toronto, Toronto, Canada10Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia11Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany12Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany13Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain14Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain15Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA16Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland17Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark18Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark19Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark20Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy21Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden22Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany23German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany24Division of Molecular Pathology, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands25Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany26Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany27Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK28Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK29Department of Biology, University of Pisa, Pisa, Italy30Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany31University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany32Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA33Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK34Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK35Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland36Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands37Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands38Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA39Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK40Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany41Genomic Medicine, Manchester Academic Health Science Centre, University of Manchester, Central Manchester Foundation Trust, St. Mary's Hospital, Manchester, UK42Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany43David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, CA, USA44Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School, Edinburgh, UK45Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany46Department of Cancer Epidemiology, Clinical Cancer Registry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany47Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark48Cancer Epidemiology & Intelligence Division, Cancer Council Victoria, Melbourne, Australia49Department of Surgery, Oulu University Hospital, University of Oulu, Oulu, Finland50Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA51Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany52Department of Biostatistics & Epidemiology, University of Massachusetts, Amherst, Amherst, MA, USA53Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland54Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland55Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland56Warwick Clinical Trials Unit, University of Warwick, Coventry, UK57Family Cancer Clinic, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands58Saarland Cancer Registry, Saarbrücken, Germany59Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands60Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA61Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland62Central Finland Health Care District, Jyväskylä Central Hospital, Jyväskylä, Finland63Division of Cancer Medicine, Peter MacCallum Cancer Center, Melbourne, Australia64Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada65Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada66Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands67Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway68Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway69Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway70VIB Center for Cancer Biology, VIB, Leuven, Belgium71Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium72University of Hawaii Cancer Center, Honolulu, HI, USA73Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden74Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA75Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Memorial Cancer Center – Oncology Institute, Warsaw, Poland76Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy77Department of Oncology – Pathology, Karolinska Institutet, Stockholm, Sweden78National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany79Anatomical Pathology, The Alfred Hospital, Melbourne, Australia80Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain81Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada82Laboratory Medicine Program, University Health Network, Toronto, Canada83Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland84Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium85Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA86Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain87Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia88Department of Medicine, St Vincent's Hospital, The University of Melbourne, Fitzroy, Australia89Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland90Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland91Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy92Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK93Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany94Research Oncology, Guy's Hospital, King's College London, London, UK95Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA96Department of Pathology, The University of Melbourne, Melbourne, Australia97Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands98Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK99Frauenklinik der Stadtklinik Baden-Baden, Baden-Baden, Germany100Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands101Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA102Servicio de Oncología Médica, Hospital Universitario La Paz, Madrid, Spain103Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia104Gynaecology Research Unit, Hannover Medical School, Hannover, Germany105Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA106Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands107IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.